Postmarketing safety profile of brexanolone: a pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS)
Meilian Zhang, Wenhuo Xie, Jianbin Li, Jiaping Zheng, Yu Zhou
Topics & Concepts
PharmacovigilanceAdverse Event Reporting SystemMedicinePostmarketing surveillanceAdverse effectDiscontinuationDepression (economics)PharmacoepidemiologyOdds ratioConfidence intervalPharmacologyPsychiatryInternal medicineMacroeconomicsMedical prescriptionEconomicsPharmacovigilance and Adverse Drug ReactionsMaternal Mental Health During Pregnancy and PostpartumPregnancy and Medication Impact